Claris Law Legal Blogging Community

Recent Entries

RSS 2.0 feed Add to My Yahoo!
Add to Bloglines Add to your My Feedster
Add to your NewsGator My MSN
Trasylol Lawyer

Aprotinin Banned in China

editor photo

Editor: Jamie Sheller
Profession: Trasylol Attorney

December 18, 2007

By Paul Napoli

TrackBack (0)

Category: Trasylol News

Aprotinin is the generic name for Trasylol. Aprotinin has been used in China as a post-surgery drug used to control bleeding. It is not manufactured by Bayer in China. Due to recent reports that Trasylol was recalled around the world, the Chinese government has banned the use of aprotinin.

"According to statistics from the National Center for ADR [Adverse Drug Reaction] Monitoring, aprotinin injections could cause adverse reactions including allergy, allergic shock, palpitation, choking, breathing with difficulty, shivering, fever, sickness and vomiting," the State Food and Drug Administration (SFDA) said in a statement posted on its website.

No adverse reactions have been reported in China.

Trasylol was recalled after a Canadian study showed that the risk of death was 50 percent higher than when similar drugs were used. Trasylol has been linked to kidney failure, heart attacks and strokes when used in conjunction with open heart surgery.

Trackback Pings

TrackBack URL for this entry:
http://myblog.clarislaw.com/usa/mt-tb.cgi/2054

Email Article



(optional):